Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2
Top Cited Papers
- 1 May 2001
- journal article
- clinical trial
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 131 (5), 541-560
- https://doi.org/10.1016/s0002-9394(01)00967-9
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?British Journal of Ophthalmology, 2000
- Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With VerteporfinArchives of Ophthalmology (1950), 1999
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Photodynamic Therapy With Verteporfin for Choroidal Neovascularization Caused by Age-related Macular DegenerationArchives of Ophthalmology (1950), 1999
- Subfoveal Neovascular Lesions in Age-Related Macular DegenerationArchives of Ophthalmology (1950), 1991